Business in the Burbs

EpiCept stock offering to raise $7.3M

October

EpiCept Corp., which develops drugs to treat cancer, expects to raise $7.3 million from the sale of 4.26 million shares of stock at a price of $1.88 a share, the company said today.

Additionally, the Eastview-based company said five-year warrants, to purchase up to about 2.13 million shares of common stock, were priced at $1.88 a share.

EpiCept intends to use the net proceeds for general corporate purposes, it said.

This entry was posted on Wednesday, October 10th, 2007 at 1:08 pm by David Schepp. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Corporate doings, Raising cash

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.